Found: 64
Select item for more details and to access through your institution.
Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 557, doi. 10.1007/s00262-002-0321-3
- By:
- Publication type:
- Article
Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 587, doi. 10.3390/vaccines12060587
- By:
- Publication type:
- Article
Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor.
- Published in:
- Sarcoma, 2015, v. 2015, p. 1, doi. 10.1155/2015/269197
- By:
- Publication type:
- Article
Antibody-Based Targeted Radiation to Pediatric Tumors.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 157S
- By:
- Publication type:
- Article
Single-Chain Fv-Streptavidin Substantially Improved Therapeutic Index in Multistep Targeting Directed at Disialoganglioside GD2.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 5, p. 867
- By:
- Publication type:
- Article
Radioimmunoscintigraphy and Pretreatment Dosimetry of <sup>131</sup>I-Omburtamab for Planning Treatment of Leptomeningeal Disease.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 946, doi. 10.2967/jnumed.122.265131
- By:
- Publication type:
- Article
Biodistribution and radiation dosimetry of intraperitoneally administered <sup>124</sup>I-omburtamab in patients with desmoplastic small round cell tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262793
- By:
- Publication type:
- Article
Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 147, doi. 10.2967/jnumed.117.193169
- By:
- Publication type:
- Article
Norepinephrine Transporter as a Target for Imaging and Therapy.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 39S, doi. 10.2967/jnumed.116.186833
- By:
- Publication type:
- Article
Arsenic Trioxide as a Radiation Sensitizer for <sup>131</sup>I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 231, doi. 10.2967/jnumed.115.161752
- By:
- Publication type:
- Article
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1106597
- By:
- Publication type:
- Article
Ovarian function in female survivors of high‐risk neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31181
- By:
- Publication type:
- Article
Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 8, p. 1, doi. 10.1002/pbc.30434
- By:
- Publication type:
- Article
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30075
- By:
- Publication type:
- Article
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mandibular metastases in neuroblastoma: Outcomes and dental sequelae.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28918
- By:
- Publication type:
- Article
Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 9, p. 1, doi. 10.1002/pbc.28364
- By:
- Publication type:
- Article
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dose-escalation is needed for gross disease in high-risk neuroblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.
- Published in:
- Pediatric Blood & Cancer, 2017, v. 64, n. 5, p. n/a, doi. 10.1002/pbc.26314
- By:
- Publication type:
- Article
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?
- Published in:
- 2016
- By:
- Publication type:
- letter
Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 3, p. 469, doi. 10.1002/pbc.23132
- By:
- Publication type:
- Article
Osteochondroma in long-term survivors of high-risk neuroblastoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 12, p. 2090, doi. 10.1002/cncr.29316
- By:
- Publication type:
- Article
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 13, p. 2050, doi. 10.1002/cncr.28687
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-G<sub>D2</sub> 3F8 monoclonal antibody.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2789, doi. 10.1002/cncr.28137
- By:
- Publication type:
- Article
Ifosfamide, carboplatin, and etoposide for neuroblastoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 665, doi. 10.1002/cncr.27783
- By:
- Publication type:
- Article
Differential Impact of High-Dose Cyclophosphamide, Topotecan, and Vincristine in Clinical Subsets of Patients With Chemoresistant Neuroblastoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 12, p. 3054, doi. 10.1002/cncr.25232
- By:
- Publication type:
- Article
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 9, p. 3260, doi. 10.1172/JCI62749
- By:
- Publication type:
- Article
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178593
- By:
- Publication type:
- Article
High-dose carboplatin-irinotecan-temozolomide: Treatment option for neuroblastoma resistant to topotecan.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 56, n. 3, p. 403, doi. 10.1002/pbc.22855
- By:
- Publication type:
- Article
Hypothyroidism after <sup>131</sup>I-monoclonal antibody treatment of neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 55, n. 1, p. 76, doi. 10.1002/pbc.22452
- By:
- Publication type:
- Article
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 53, n. 7, p. 1340, doi. 10.1002/pbc.22243
- By:
- Publication type:
- Article
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 53, n. 1, p. 17, doi. 10.1002/pbc.21931
- By:
- Publication type:
- Article
Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 52, n. 2, p. 304, doi. 10.1002/pbc.21776
- By:
- Publication type:
- Article
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: Possible leukemogenic role of temozolomide.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 51, n. 4, p. 552, doi. 10.1002/pbc.21658
- By:
- Publication type:
- Article
Transient sialoadenitis: A complication of <sup>131</sup>I-metaiodobenzylguanidine therapy.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 6, p. 1271, doi. 10.1002/pbc.21391
- By:
- Publication type:
- Article
Brain-sparing radiotherapy for neuroblastoma skull metastases.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 6, p. 1163, doi. 10.1002/pbc.21384
- By:
- Publication type:
- Article
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: Broad implications for immunotherapy.
- Published in:
- Pediatric Blood & Cancer, 2007, v. 48, n. 4, p. 430, doi. 10.1002/pbc.20765
- By:
- Publication type:
- Article
Liver involvement in neuroblastoma: The memorial Sloan-Kettering experience supports treatment reduction in young patients.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 46, n. 3, p. 278, doi. 10.1002/pbc.20564
- By:
- Publication type:
- Article
Long-term complications in survivors of advanced stage neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2005, v. 45, n. 3, p. 324, doi. 10.1002/pbc.20331
- By:
- Publication type:
- Article
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6265, doi. 10.3390/cancers13246265
- By:
- Publication type:
- Article
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 817, doi. 10.3390/cancers13040817
- By:
- Publication type:
- Article